Trusted News Discovery Since 2008
{{/content}}
1 in 3 Covaxin recipients hit by adverse events: Study
Credit: IndiaTimes- Published on May 16, 2024
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual abnormalities in 5% of women. AstraZeneca's vaccine technology controversy and Covishield's development by the Serum Institute of India...
You are here
💡 newsR Knowledge: Other News Mentions
Related news from verified sources
Indian Council of Medical Research criticizes a recently-published study on Covaxin's safety analysis for poor methodology. The study wrongly acknowledges ICMR....
on May 20, 2024 • IndiaTimes
A study from BHU analyzing the lasting impacts of Bharat Biotech's Covaxin found nearly a third of recipients reported adverse events of special interest (AESI)....
on May 16, 2024 • IndiaTimes